Item 2.02 Results of Operations and Financial Condition.

On November 13, 2012, Galena Biopharma, Inc. ("we," "us," "our" or the "Company") issued a press release announcing our financial results for the quarter ended September 30, 2012, as well as certain recent business developments. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

The information furnished under this Item 2.02, including the accompanying Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of such section, nor shall such information be deemed to be incorporated by reference in any subsequent filing by us under the Securities Act of 1933 or the Exchange Act, regardless of the general incorporation language of such filing, except as specifically stated in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release of Galena Biopharma, Inc. dated November 13, 2012.

---